ALLMedicine™ Valvular Heart Disease Center

Apr 18th, 2021 - 4D Flow CMR: The Final Frontier in Valvular Heart Disease?|2021|Shah DJ,|

Apr 13th, 2021 - This article provides an overview of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology on sports participation in individuals with valvular heart disease (VHD). The aim of these recommendat...

Apr 11th, 2021 - Surgical replacement remains the primary option to treat the rapidly growing number of patients with severe valvular heart disease. While current valve replacements - mechanical, bioprosthetic, and cryopreserved homografts - enhance survival and q...

Apr 6th, 2021 - Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe aortic stenosis, while the indication has recently broadened to younger patients at lower risk. Although thromboembolic and bleeding complication...

Apr 5th, 2021 - Mitral valve regurgitation (MR) is a common valvular heart disease where improper closing causes leakage. Currently, no transcatheter mitral valve device is commercially available. Raanani (co-author) and colleagues have previously proposed a uniq...

May 12th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

Apr 23rd, 2019 - 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American S...

Nov 20th, 2017 - 2017 ESC/EACTS Guidelines for the management of valvular heart disease.|2017|Falk V,Baumgartner H,Bax JJ,De Bonis M,Hamm C,|standards,standards,surgery,standards,

Sep 6th, 2017 - Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.|2017|Chambers JB,Prendergast B,Iung B,Rosenhek R,Zamorano JL,|organization & administration,stand...

Aug 31st, 2017 - This document assesses a wide array of imaging modalities available to the clinician in the evaluation of patients with VHD. Presented here is a broad spectrum of clinical scenarios in such patients.

Apr 18th, 2021 - 4D Flow CMR: The Final Frontier in Valvular Heart Disease?|2021|Shah DJ,|

Apr 13th, 2021 - This article provides an overview of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology on sports participation in individuals with valvular heart disease (VHD). The aim of these recommendat...

Apr 11th, 2021 - Surgical replacement remains the primary option to treat the rapidly growing number of patients with severe valvular heart disease. While current valve replacements - mechanical, bioprosthetic, and cryopreserved homografts - enhance survival and q...

Apr 6th, 2021 - Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe aortic stenosis, while the indication has recently broadened to younger patients at lower risk. Although thromboembolic and bleeding complication...

Apr 5th, 2021 - Mitral valve regurgitation (MR) is a common valvular heart disease where improper closing causes leakage. Currently, no transcatheter mitral valve device is commercially available. Raanani (co-author) and colleagues have previously proposed a uniq...

Jan 31st, 2021 - The American College of Cardiology (ACC) and American Heart Association (AHA) released their updated recommendations on managing valvular heart disease in December 2020.[1,2] Ten key messages are outlined below. Top 10 Take-Home Messages Valvular ...

Jan 3rd, 2021 - The latest iteration of the American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease emphasizes a less invasive approach to the management of patients with valvular he...

Oct 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Danny Dvir, MD, has a message for physicians who have patients with severe valvular heart disease who are deferring valve replacement or repair un...

Oct 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Danny Dvir, MD, has a message for physicians who have patients with severe valvular heart disease who are deferring valve replacement or repair un...

Oct 6th, 2020 - 2. Managing comorbid conditions is important. Although HFpEF is frequently characterized by its phenotypic heterogeneity, most patients also present with a host of other discrete, treatable medical comorbidities, such as hypertension, valvular hea...